Wal Drugs offered an incentive stock option plan to its employees. On January 1, 2021 options were granted for 62.500 s1 por common shares. The exercise price equals the $3 market price of the common stock on the grant date. The options cannot be exercised before January 1, 2024, and expire December 31, 2025. Each option has a fair value of $1 based on an option pricing model which is the correct entry to record the exercise of 70% the options on April 15, 2024, when the market price of the stock was $67 Mot Choice Paid in capital-stock options Coenon stock Paldin capital excess of par 131.250 63.250 162.500 1112.500 Cash Paid-in capital-stock options Comance stock Paldin Capital-ecot par 218,750 43.750 43,750 21,750 Cash Paldin capitale stock optat Compensato per 121.250 62.750 17.500 R x M 26 26 Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 131,250 43,750 62,500 112,500 Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 218,750 43, 750 43,750 218,750 Cash Paid-in capital-stock options Compensation expense Common stock Paid-in capital-excess of par 131,250 43,750 87,500 43,750 218.750 Cash Paid-in capital-stock options Common stock Paid-in capital-excess of par 131,250 43, 7501 43,750 131,250 AN R C O F G K B N M V. 30